• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Pear Therapeutics launches program to offer digital therapeutics through telehealth platforms

April 4, 2022 By Sean Whooley

Pear TherapeuticsPear Therapeutics (Nasdaq:PEAR) announced today that it launched a program to offer digital therapeutic users access to a telehealth provider.

Boston-based Pear’s program offers patients seeking treatment for substance use disorder (SUD) or opioid use disorder (OUD) access to a telehealth provider through its “find a provider tool,” as well as in-person care options.

According to a news release, the company plans to work with select telehealth providers to connect patients with a clinician to go over treatment options, including the reSET and reSET-O prescription digital therapeutics (PDTs). The first offering comes through telehealth addiction treatment provider PursueCare with a digital health model for SUD and OUD treatment.

“We find patients are often required to piece together their treatment like a puzzle. By bringing together and standardizing delivery of comprehensive at-home and digital care solutions, we put the patient at the center and bring them the resources and proven remote behavioral interventions they need, along with treatment from skilled clinicians who can help them navigate their journey,” PursueCare founder and CEO Nick Mercadante said in the release. “I believe this approach truly drives value-based care and is too often lacking for people who have a substance use disorder and are seeking access to recovery treatment.”

Pear said that, through collaboration with telehealth providers, it can provide an integrated virtual treatment continuum to give patients access to learn about its 24/7 evidence-based therapeutic that can complement outpatient medical treatment.

PursueCare’s virtual care platform offers medication-assisted treatment (MAT), counseling, psychiatry, delivery pharmacy, at-home screenings and targeted case management through one app. Pear said it already launched the combined offering with PursueCare in select markets across PursueCare’s 12-state footprint and plans are in place for expansion to additional states.

“About only one in 10 Americans with a substance use disorder receives any type of specialty treatment. Barriers to care can include not having access to in-person therapy or long waiting periods to engage care. The power of Pear working with telehealth providers like PursueCare is meeting patients where they are,” Pear President and CEO Dr. Corey McCann said. “We need to make it easier for patients with addiction to seek and learn about treatment options for recovery. By providing innovative, fully virtual evidence-based care and treatment, we can create equity of access, and remove many of the obstacles associated with treatment.”

Filed Under: Big Data, Business/Financial News, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: Pear Therapeutics, PursueCare

IN CASE YOU MISSED IT

  • Nuvo, Sheba Medical Center develop AI-powered gestational diabetes management platform
  • Verily’s Onduo, Sword Health collaborate on virtual diabetes care
  • Shareholder lawsuit over BD’s Alaris pumps recall moves forward
  • Embecta stock soars on first full-quarter results after BD spinoff
  • Abbott will spend $450M to up FreeStyle Libre production in Ireland

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS